Interleukin-6 is expressed by plasma cells from patients with multiple myeloma and monoclonal gammopathy of undetermined significance

British Journal of Haematology

Volumn 101, Issue 2, 1998, Pages 287-295

  Sati, Hamdi I A ^a   Apperley, Jane F ^b   Greaves, Mike ^c   Lawry, John ^d   Gooding, Roger ^b   Russell, R Graham G ^a   Croucher, Peter I ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Fluorescence in situ hybridization; Immunoglobulin light chain; Interleukin 6; Monoclonal gammopathy of undertermined significance; Multiple myeloma

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN; INTERLEUKIN 6; MESSENGER RNA;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN PRODUCTION; MALE; MESSENGER RNA SYNTHESIS; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; COLOR; FEMALE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERLEUKIN-6; MALE; MIDDLE AGED; MONOCLONAL GAMMOPATHIES, BENIGN; MULTIPLE MYELOMA; PLASMA CELLS;

EID: 0031810469     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00687.x     Document Type: Article

References (30)

1. Anderson, K.C., Jones, R.M., Morimoto, C., Leavitt, P. & Barut, B.A. (1989) Response patterns of purified myeloma cells to hematopoietic growth factors. Blood, 73, 1915-1924.
2. Bakkus, M.H.C., Brakle-Van Peer, K.M.J., Adraansen, H.J., Van Den Akker, T.W. & Benner, R. (1991) Detection of interleukin-1β and interleukin-6 in human multiple myeloma by fluorescent in situ hybridisation. Leukemia and Lymphoma, 4, 389-395.
3. Barille, S., Collette, M., Bataille, R. & Amiot, M. (1995) Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin. Blood, 86, 3151-3159.
4. Bataille, R., Barlogie, B., Lu, Z.Y., Rossi, J.F., Lavabre-Bertrand, T., Beck, T., Wijdenes, J., Brochier, J. & Klein, B. (1995) Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma. Blood, 86, 685-691.
5. Caligaris-Cappio, F., Bergui, L., Gregoretti, M.G., Gaidano, G., Gaboli, M., Schena, M., Zambin-Zallone, A. & Marchisio, P.C. (1991) Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood, 77, 2688-2693.
6. Goto, H., Shimazaki, C., Tatsumi, T., Yamagata, N., Fujita, N., Tsuchiya, M., Koishihara, Y., Ohsugi, Y. & Nakagawa, M. (1995) Establishment of a novel myeloma cell line KPMM2 carrying t(3;14) (q21;q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanism. Leukemia, 9, 711-718.
7. Gu, Z.J., Costes, V., Lu, Z.Y., Zhang, X.G., Pitard, V., Moreau, J.F., Bataille, R., Wijdenes, J., Rossi, J.F. & Klein, B. (1996) Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop. Blood, 88, 3972-3986.
8. Hata, H., Xiao, H., Petrucci, M.T., Woodliff, J., Chang, R. & Epstein, J. (1993) Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood, 81, 3357-3364.
9. Jung, T., Schauer, U., Heusser, C., Neumann, C. & Rieger, C. (1993) Detection of intracellular cytokines by flow cytometry. Journal of Immunological Methods, 159, 197-207.
10. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A. & Kishimoto, T. (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature, 332, 83-85.
11. Kawano, M.M., Huang, N., Harada, H., Harada, Y., Sakai, A., Tanaka, H., Iwato, K. & Kuramoto, A. (1993) Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood, 82, 564-570.
12. Klein, B., Wijdenes, J., Zhang, X.G., Jourdan, M., Boiron, J.M., Brochier, J., Liautard, J., Merlin, M., Clement, C., Morel-Fournier, B., Lu, Z.-Y., Mannoni, P., Sany, J. & Bataille, R. (1991) Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood, 78, 1198-1204.
13. Klein, B., Zhang, X.G., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M. & Bataille, R. (1989) Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood, 73, 517-526.
14. Klein, B., Zhang, X.G., Lu, Z.Y. & Bataille, R. (1995) Interleukin-6 in human multiple myeloma. Blood, 85, 863-872.
15. Levy, Y., Tsapis, A. & Brouet, J.-C. (1991) Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines. Journal of Clinical Investigation, 88, 696-699.
16. Lichtenstein, A., Tu, Y., Fady, C., Vescio, R. & Berenson, J. (1995) Interleukin-6 inhibits apoptosis of malignant plasma cells. Cellular Immunology, 162, 248-255.
17. Lokhorst, H.M., Lamme, T., de Smet, M., Klein, S., de Wege, R.A., van Oers, R. & Bloem, A.C. (1994) Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood, 84, 2269-2277.
18. Ludwig, H., Nachbaur, D.M., Fritz, E., Krainer, M. & Huber, H. (1991) Interleukin-6 is a prognostic factor in multiple myeloma. Blood, 77, 2794-2795.
19. + mature myeloma cells. International Journal of Hematology, 63, 215-226.
20. Ohtake, K., Yano, T., Kameda, K. & Ogawa, T. (1990) Detection of interleukin-6 (IL-6) in human bone marrow myeloma cells by light and electron microscopy. American Journal of Hematology, 35, 84-87.
21. Ozaki, S., Wolfenbarger, D., de Bram-Hart, M., Kanangatm, S., Weissm, D.T. & Solomon, A. (1994) Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line. Leukemia, 8, 2207-2213.
22. Pellat-Deceunynck, C., Bataille, R., Robillard, N., Harousseau, J.L., Rapp, M.J., Juge Morineau, N., Wijdenes, J. & Amiot, M. (1994) Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. Blood, 84, 2597-2603.
23. Pelliniemi, T.T., Irjala, K., Mattila, K., Pulkki, K., Rajamaki, A., Tienhaara, A., Laakso, M. & Lahtinen, R. (1995) Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group. Blood, 85, 765-771.
24. Portier, M., Rajzbaum, G., Zhang, X.G., Attal, M., Rusalen, C., Wijdenes, J., Mannoni, P., Maraninchi, D., Piechaczyk, M., Bataille, R. & Klein, B. (1991) In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma. European Journal of Immunology, 21, 1759-1762.
25. Schwab, G., Siegall, C.B., Aarden, L.A., Neckers, L.M. & Nordan, R.P. (1991) Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line. U266, Blood, 77, 587-593.
26. Solary, E., Guiguet, M., Zeller, V., Casasnovas, R.O., Caillot, D., Chavanet, P., Guy, H. & Mack, G. (1992) Radioimmunoassay for the measurement of serum IL-6 and its correlation with tumor cell mass parameters in multiple myeloma. American Journal of Hematology, 39, 163-171.
27. Urashima, M., Chauhan, D., Uchiyama, H., Freeman, G.J. & Anderson, K.C. (1995) CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood, 85, 1903-1912.
28. Westendorf, J.J., Ahmann, G.J., Armitage, R.J., Spriggs, M.K., Lust, J.A., Greipp, P.R., Katzmann, J.A. & Jelinek, D.F. (1994) CD40 expression in malignant plasma cells: role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. Journal of Immunology, 152, 117-128.
29. Westendorf, J.J., Ahmann, G.J., Greipp, P.R., Witzig, T.E., Lust, J.A. & Jelinek, D.F (1996) Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6. Leukemia, 10, 866-876.
30. Zhang, X.G., Gaillard, J.P., Robillard, N., Lu, Z.Y., Gu, Z.J., Jourdan, M., Boiron, J.M., Bataille, R. & Klein, B. (1994) Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood, 83, 3654-3663.